Table 3.

Comparison of observed and pseudo-IOCv2 scores in the test set (N = 392)

IOCv2 Scale	Observed IOCv2 score	Pseudo- IOCv2 score	Difference: Mean ± SD (min, max)	r, total test sample (N = 392)	r, breast cancer survivors in test sample (N = 253)	r, non-Hodgkin lymphoma survivors in test sample (N = 139)
Meaning of Cancer subscale	2.93 ± 0.92	2.93 ± 0.88	0.006 ± 0.153 (−0.42, 0.69)	0.986	0.984	0.989
Positive Self-Evaluation subscale	3.90 ± 0.79	3.90 ± 0.74	−0.002 ± 0.172 (−0.68, 0.58)	0.976	0.978	0.976
Life Interferences subscale	1.97 ± 0.66	1.95 ± 0.44	0.021 ± 0.329 (−0.65, 1.31)	0.896	0.920	0.864
Worry subscale	2.74 ± 0.90	2.72 ± 0.87	0.011 ± 0.010 (−0.29, 0.39)	0.994	0.994	0.995
Positive Impact Summary scale	3.52 ± 0.65	3.52 ± 0.64	0.001 ± 0.061 (−0.17, 0.20)	0.996	0.996	0.996
Negative Impact Summary scale	2.38 ± 0.71	2.37 ± 0.64	0.010 ± 0.128 (−0.27, 0.48)	0.988	0.988	0.988